ACKR1 |
Q16570
|
atypical chemokine receptor 1 (Duffy blood group)
|
G-protein coupled receptor
|
2.1E-04 |
0.608 |
0.731 |
ACKR2 |
O00590
|
atypical chemokine receptor 2
|
G-protein coupled receptor
|
1.4E-03 |
0.641 |
0.615 |
ACVR1B |
P36896
|
activin A receptor type 1B
|
Kinase
|
1.00 |
0.663 |
0.385 |
AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |
ARHGAP23 |
Q9P227
|
Rho GTPase activating protein 23
|
|
1.00 |
0.931 |
0.115 |
ATXN1 |
P54253
|
ataxin 1
|
|
0.97 |
0.534 |
0.769 |
ATXN2 |
Q99700
|
ataxin 2
|
Nucleic acid binding
|
0.85 |
0.482 |
0.808 |
AZIN1 |
O14977
|
antizyme inhibitor 1
|
Enzyme
|
0.99 |
0.716 |
0.462 |
BCL2L13 |
Q9BXK5
|
BCL2 like 13
|
|
2.4E-03 |
0.780 |
0.308 |
C11orf65 |
Q8NCR3
|
chromosome 11 open reading frame 65
|
|
2.0E-14 |
0.670 |
0.462 |
C18orf25 |
Q96B23
|
chromosome 18 open reading frame 25
|
|
0.89 |
0.931 |
0.231 |
CA11 |
O75493
|
carbonic anhydrase 11
|
|
9.6E-04 |
0.674 |
0.385 |
CADM3-AS1 |
|
CADM3 antisense RNA 1
|
|
|
1.000 |
0.038 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
CCDC125 |
Q86Z20
|
coiled-coil domain containing 125
|
|
8.6E-10 |
0.890 |
0.154 |
CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
CD300LF |
Q8TDQ1
|
CD300 molecule like family member f
|
|
1.1E-08 |
0.716 |
0.385 |
CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
CHD7 |
Q9P2D1
|
chromodomain helicase DNA binding protein 7
|
|
1.00 |
0.441 |
0.846 |
CHSY1 |
Q86X52
|
chondroitin sulfate synthase 1
|
Enzyme
|
0.71 |
0.612 |
0.615 |
COQ8A |
Q8NI60
|
coenzyme Q8A
|
Kinase
|
9.3E-11 |
0.674 |
0.385 |
CREB5 |
Q02930
|
cAMP responsive element binding protein 5
|
Transcription factor
|
0.22 |
0.682 |
0.538 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
CSF3R |
Q99062
|
colony stimulating factor 3 receptor
|
Signaling
|
1.5E-10 |
0.550 |
0.692 |